Cartiva competitorsClear all
Fusion Antibodies's top competitors include Tissue Regenix Group, Orthofix and Affymetrix.
| Save Comparison |  Fusion Antibodies Fusion Antibodies is a CRO that offers a range of world class services in antibody production, development, characterization and optimization. |  Tissue Regenix Group Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement. |  Orthofix Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. |  Affymetrix Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level. |
Founding Date | Founding Date 2001 | Founding Date 2006 | Founding Date 1980 | Founding Date 1994 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Belfast, GB HQ | Locations Swillington, GB HQ San Antonio, US | Locations Z.a.i., IT HQ São Paulo, BR Willemstad, CW Arcueil, FR Ottobrunn, DE Sona, IT San Juan, PR see more | |
Employees | Employees 323% increase | Employees 61 | Employees 95411% increase | Employees N/A |
Valuation ($) | Valuation ($) N/A | Valuation ($) 129.7 m | Valuation ($) 1 b | Valuation ($) N/A |
Twitter followers | Twitter followers 967 | Twitter followers 731 | Twitter followers N/A | Twitter followers 3 |
Alexa Website Rank | Alexa Website Rank 1032809 | Alexa Website Rank 638427 | Alexa Website Rank 298367 | Alexa Website Rank 454220 |
Financial | ||||
Revenue (est.) | Revenue (est.) £2.2m (FY, 2019) | Revenue (est.) £11.6m (FY, 2018) | Revenue (est.) $453m (FY, 2018) | Revenue (est.) $359.8m (FY, 2015) |
Cost of goods | Cost of goods £1.4m (FY, 2019) | Cost of goods £5.7m (FY, 2018) | Cost of goods $96.6m (FY, 2018) | Cost of goods $110.8m (FY, 2015) |
Gross profit | Gross profit £804k (FY, 2019) | Gross profit £5.9m (FY, 2018) | Gross profit $356.4m (FY, 2018) | Gross profit $249m (FY, 2015) |
Net income | Net income (£1.3m) (FY, 2019) | Net income (£8.3m) (FY, 2018) | Net income $13.8m (FY, 2018) | Net income $10.1m (FY, 2015) |
For sources of this data, please see the company profile
View company profiles
Tissue Regenix Group
HQ
Swillington, GB
Employees
61
Tissue Regenix uses its patented dCELL technology to address many clinical needs such as sports medicine, wound care and heart valve replacement.
View companyOrthofix
HQ
Z.a.i., IT
Employees
954↑ 11% increase
Orthofix International is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide.
View companyAffymetrix
HQ
Santa Clara, US
Affymetrix develops and provides technologies that enable multiplex and parallel analysis of biological systems at the cell protein, and gene level.
View company